Estás usando un navegador no soportado
Usar Internet Explorer está desaconsejado por problemas de seguridad. Para ver correctamente esta web, por favor use cualquier navegador moderno: Chrome, Firefox, Edge, Safari u otro de su elección.
En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias
FILTRAR POR:
358 ARTÍCULOS , VIENDO DEL 121 AL 135
Wei S.
Fundam Clin Pharmacol. 2016 Dec;30(6):490-501. doi: 10.1111/fcp.12222. Epub 2016 Aug 5.
Tau-Centric Targets and Drugs in Clinical Development for the Treatment of Alzheimer's Disease
Panza F, Solfrizzi V, Seripa D, Imbimbo BP, Lozupone M, Santamato A, Zecca C, Barulli MR, Bellomo A, Pilotto A, Daniele A, Greco A, Logroscino G.
Biomed Res Int. 2016;2016:3245935. doi: 10.1155/2016/3245935. Epub 2016 Jun 26.
Changes in insulin and insulin signaling in Alzheimer's disease: cause or consequence?
Stanley M, Macauley SL, Holtzman DM.
J Exp Med. 2016 Jul 25;213(8):1375-85. doi: 10.1084/jem.20160493. Epub 2016 Jul 18.
Pharmacotherapeutic strategies in the treatment of severe Alzheimer's disease
Deardorff WJ, Grossberg GT.
Expert Opin Pharmacother. 2016 Sep;17(13):1789-800. doi: 10.1080/14656566.2016.1215431. Epub 2016 Jul 29.
Potential Therapeutic Effects of Oleuropein Aglycone in Alzheimer's Disease
Martorell M, Forman K, Castro N, Capó X, Tejada S, Sureda A.
Curr Pharm Biotechnol. 2016;17(11):994-1001. doi: 10.2174/1389201017666160725120656.
Old and new acetylcholinesterase inhibitors for Alzheimer's disease
Galimberti D, Scarpini E.
Expert Opin Investig Drugs. 2016 Oct;25(10):1181-7. doi: 10.1080/13543784.2016.1216972. Epub 2016 Aug 5.
[Progress of clinical trials in Alzheimer’s disease drugs]
Peng Y, Li PP, Li L, Zhang Y, Hou WZ, Cui DD, Li J, Wang L, Wang QL, Wang XL.
Yao Xue Xue Bao. 2016 Aug;51(8):1185-95.
Weeks J.
J Altern Complement Med. 2016 Aug;22(8):585-7. doi: 10.1089/acm.2016.29008.jjw.
Older patients are still under-represented in clinical trials of Alzheimer's disease
Banzi R, Camaioni P, Tettamanti M, Bertele' V, Lucca U.
Alzheimers Res Ther. 2016 Aug 12;8:32. doi: 10.1186/s13195-016-0201-2.
Treatment strategies in Alzheimer's disease: a review with focus on selenium supplementation
Aaseth J, Alexander J, Bjørklund G, Hestad K, Dusek P, Roos PM, Alehagen U.
Biometals. 2016 Oct;29(5):827-39. doi: 10.1007/s10534-016-9959-8. Epub 2016 Aug 16.
Editorial (Thematic Issue: Current and Perspective Therapeutic Strategies for Alzheimer's Disease)
Piccionello AP, Cappello F.
Curr Pharm Des. 2016;22(26):3935-6. doi: 10.2174/138161282226160801224800.
Editorial: Combining Forces to Improve Alzheimer's Disease Drug Discovery: The Symptomatic Battle
Deguil J, Auffret A, Schenker E, Aujard F, Lamberty Y, Bartrès-Faz D, Blin O, Micallef J, Richardson JC, Bordet R.
CNS Neurol Disord Drug Targets. 2016;15(7):754-5. doi: 10.2174/187152731507160808200737.
Perspectives for treating Alzheimer's disease: a review on promising pharmacological substances
Cazarim Mde S, Moriguti JC, Ogunjimi AT, Pereira LR.
Sao Paulo Med J. 2016 Jul-Aug;134(4):342-54. doi: 10.1590/1516-3180.2015.01980112.
Neuroprotective properties of mitochondria-targeted antioxidants of the SkQ-type
Isaev NK, Stelmashook EV, Genrikhs EE, Korshunova GA, Sumbatyan NV, Kapkaeva MR, Skulachev VP.
Rev Neurosci. 2016 Dec 1;27(8):849-855. doi: 10.1515/revneuro-2016-0036.
Natural Compounds and Neuroprotection: Mechanisms of Action and Novel Delivery Systems
Bagli E, Goussia A, Moschos MM, Agnantis N, Kitsos G.
In Vivo. 2016 09-10;30(5):535-47.
Actualización mensual Regístrese para recibir los avisos de actualización
Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.